Clinical Practice of Inhalation Anesthesia With Sevoflurane in China

Study Identifier
P13-934
CT.gov Identifier
NCT01715857
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Neuroscience - Other
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 70 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    1. Man or woman, aged from 18 to 70 years old. 2. American Society of Anesthesiologists (ASA) physical status: I, II and III. 3. Surgery requiring sevoflurane anesthesia with endotracheal intubation or laryngeal mask airway (LMA). 4. The type of surgery is either general surgery, or orthopedics, or gynecology. 5. The duration of anesthesia ranges from 1 to 5 hours.
    Exclusion Criteria:
    1. History of clinically significant cardiovascular, pulmonary, renal, hepatic or central nervous system or muscle disease. 2. Known hypersensitivity or history of unusual response to any halogenated anesthetics. 3. Personal or familial history of malignant hyperthermia. 4. Female patients who are either pregnant or breast feeding. 5. General anesthesia is administered with total intravenous anesthesia (TIVA) of propofol or sevoflurane maintenance combined with propofol continuous infusion during maintenance.

    Protocol Summary

    Until recently, there was a lack of understanding and consensus among Chinese anesthesiologists how they should practice general anesthesia with volatile anesthetics, since there was no standard of inhalation practice. In August 2011, the Anesthesiology branch of the Chinese Medical Association launched the first version of Chinese Consensus of Standard Clinical Practice for Inhalation Anesthesia (Consensus) in order to standardize the practice in China.

    The proposed registry is aimed to evaluate the current inhalation practice one year after the Consensus has been released, and related patient outcome. This registry evaluated sevoflurane anesthesia, including screening, induction, maintenance, emergence, and follow-up within 24 hours post-operation.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 84317
    Beijing, China, 100000
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 86755
    Beijing, China, 100029
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 96155
    Beijing, China, 100191
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 84320
    Beijing, China, 100730
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 84316
    Beijing, Xicheng District, China, 100044
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 84321
    Changchun, Jilin, China, 130031
    Status
    Not applicable
    Showing {first} - {last} of {total} Results